vs
安进（AMGN）与Quanta Services（PWR）财务数据对比。点击上方公司名可切换其他公司
安进的季度营收约是Quanta Services的1.3倍（$9.9B vs $7.8B），安进净利率更高（13.5% vs 4.0%，领先9.5%），Quanta Services同比增速更快（19.7% vs 8.6%），安进自由现金流更多（$961.0M vs $934.0M），过去两年Quanta Services的营收复合增速更高（24.8% vs 15.1%）
安进是总部位于美国加利福尼亚州千橡市的跨国生物制药企业，公司名称取自最初的全称「应用分子遗传学」的缩写组合，按营收规模排名位列全球生物医药企业第18位，专注于研发、生产及商业化创新生物药物，为全球患者提供优质治疗选择。
Quanta Services是美国基础设施服务企业，业务覆盖电力、管道、工业、通信四大领域，可提供各类网络基础设施的规划、设计、安装、项目管理、运维及维修服务。公司自成立以来除内生增长外，已累计收购超150家电力承包领域相关企业。
AMGN vs PWR — 直观对比
营收规模更大
AMGN
是对方的1.3倍
$7.8B
营收增速更快
PWR
高出11.1%
8.6%
净利率更高
AMGN
高出9.5%
4.0%
自由现金流更多
AMGN
多$27.0M
$934.0M
两年增速更快
PWR
近两年复合增速
15.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.9B | $7.8B |
| 净利润 | $1.3B | $316.6M |
| 毛利率 | 69.8% | 15.5% |
| 营业利润率 | 27.6% | 6.2% |
| 净利率 | 13.5% | 4.0% |
| 营收同比 | 8.6% | 19.7% |
| 净利润同比 | 112.6% | 2.0% |
| 每股收益（稀释后） | $2.45 | $2.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMGNPWR
| Q4 25 | $9.9B | $7.8B | ||
| Q3 25 | $9.6B | $7.6B | ||
| Q2 25 | $9.2B | $6.8B | ||
| Q1 25 | $8.1B | $6.2B | ||
| Q4 24 | $9.1B | $6.6B | ||
| Q3 24 | $8.5B | $6.5B | ||
| Q2 24 | $8.4B | $5.6B | ||
| Q1 24 | $7.4B | $5.0B |
净利润AMGNPWR
| Q4 25 | $1.3B | $316.6M | ||
| Q3 25 | $3.2B | $339.4M | ||
| Q2 25 | $1.4B | $229.3M | ||
| Q1 25 | $1.7B | $144.3M | ||
| Q4 24 | $627.0M | $310.3M | ||
| Q3 24 | $2.8B | $293.2M | ||
| Q2 24 | $746.0M | $188.2M | ||
| Q1 24 | $-113.0M | $118.4M |
毛利率AMGNPWR
| Q4 25 | 69.8% | 15.5% | ||
| Q3 25 | 67.8% | 15.9% | ||
| Q2 25 | 67.2% | 14.9% | ||
| Q1 25 | 63.6% | 13.4% | ||
| Q4 24 | 65.7% | 16.2% | ||
| Q3 24 | 61.1% | 15.6% | ||
| Q2 24 | 61.4% | 14.5% | ||
| Q1 24 | 57.0% | 12.4% |
营业利润率AMGNPWR
| Q4 25 | 27.6% | 6.2% | ||
| Q3 25 | 26.4% | 6.8% | ||
| Q2 25 | 28.9% | 5.5% | ||
| Q1 25 | 14.5% | 3.8% | ||
| Q4 24 | 25.4% | 6.9% | ||
| Q3 24 | 24.1% | 6.6% | ||
| Q2 24 | 22.8% | 5.5% | ||
| Q1 24 | 13.3% | 3.1% |
净利率AMGNPWR
| Q4 25 | 13.5% | 4.0% | ||
| Q3 25 | 33.7% | 4.4% | ||
| Q2 25 | 15.6% | 3.4% | ||
| Q1 25 | 21.2% | 2.3% | ||
| Q4 24 | 6.9% | 4.7% | ||
| Q3 24 | 33.3% | 4.5% | ||
| Q2 24 | 8.9% | 3.4% | ||
| Q1 24 | -1.5% | 2.4% |
每股收益（稀释后）AMGNPWR
| Q4 25 | $2.45 | $2.08 | ||
| Q3 25 | $5.93 | $2.24 | ||
| Q2 25 | $2.65 | $1.52 | ||
| Q1 25 | $3.20 | $0.96 | ||
| Q4 24 | $1.17 | $2.03 | ||
| Q3 24 | $5.22 | $1.95 | ||
| Q2 24 | $1.38 | $1.26 | ||
| Q1 24 | $-0.21 | $0.79 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $9.1B | $439.5M |
| 总债务越低越好 | $54.6B | $5.2B |
| 股东权益账面价值 | $8.7B | $8.9B |
| 总资产 | $90.6B | $24.9B |
| 负债/权益比越低杠杆越低 | 6.31× | 0.59× |
8季度趋势，按日历期对齐
现金及短期投资AMGNPWR
| Q4 25 | $9.1B | $439.5M | ||
| Q3 25 | $9.4B | $610.4M | ||
| Q2 25 | $8.0B | $509.5M | ||
| Q1 25 | $8.8B | $520.6M | ||
| Q4 24 | $12.0B | $742.0M | ||
| Q3 24 | $9.0B | $764.1M | ||
| Q2 24 | $9.3B | $518.1M | ||
| Q1 24 | $9.7B | $531.1M |
总债务AMGNPWR
| Q4 25 | $54.6B | $5.2B | ||
| Q3 25 | $54.6B | $5.5B | ||
| Q2 25 | $56.2B | $4.7B | ||
| Q1 25 | $57.4B | $4.4B | ||
| Q4 24 | $60.1B | $4.1B | ||
| Q3 24 | $60.4B | $4.1B | ||
| Q2 24 | $62.6B | $3.0B | ||
| Q1 24 | $64.0B | $3.2B |
股东权益AMGNPWR
| Q4 25 | $8.7B | $8.9B | ||
| Q3 25 | $9.6B | $8.4B | ||
| Q2 25 | $7.4B | $7.9B | ||
| Q1 25 | $6.2B | $7.5B | ||
| Q4 24 | $5.9B | $7.3B | ||
| Q3 24 | $7.5B | $7.1B | ||
| Q2 24 | $5.9B | $6.6B | ||
| Q1 24 | $5.0B | $6.4B |
总资产AMGNPWR
| Q4 25 | $90.6B | $24.9B | ||
| Q3 25 | $90.1B | $22.7B | ||
| Q2 25 | $87.9B | $19.9B | ||
| Q1 25 | $89.4B | $19.1B | ||
| Q4 24 | $91.8B | $18.7B | ||
| Q3 24 | $90.9B | $18.9B | ||
| Q2 24 | $90.9B | $15.9B | ||
| Q1 24 | $93.0B | $15.5B |
负债/权益比AMGNPWR
| Q4 25 | 6.31× | 0.59× | ||
| Q3 25 | 5.67× | 0.66× | ||
| Q2 25 | 7.57× | 0.59× | ||
| Q1 25 | 9.24× | 0.58× | ||
| Q4 24 | 10.23× | 0.56× | ||
| Q3 24 | 8.02× | 0.58× | ||
| Q2 24 | 10.57× | 0.45× | ||
| Q1 24 | 12.75× | 0.50× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.6B | $1.1B |
| 自由现金流经营现金流 - 资本支出 | $961.0M | $934.0M |
| 自由现金流率自由现金流/营收 | 9.7% | 11.9% |
| 资本支出强度资本支出/营收 | 6.5% | 2.5% |
| 现金转化率经营现金流/净利润 | 1.20× | 3.56× |
| 过去12个月自由现金流最近4个季度 | $8.1B | $1.6B |
8季度趋势，按日历期对齐
经营现金流AMGNPWR
| Q4 25 | $1.6B | $1.1B | ||
| Q3 25 | $4.7B | $563.5M | ||
| Q2 25 | $2.3B | $295.7M | ||
| Q1 25 | $1.4B | $243.2M | ||
| Q4 24 | $4.8B | $712.0M | ||
| Q3 24 | $3.6B | $739.9M | ||
| Q2 24 | $2.5B | $391.3M | ||
| Q1 24 | $689.0M | $238.0M |
自由现金流AMGNPWR
| Q4 25 | $961.0M | $934.0M | ||
| Q3 25 | $4.2B | $421.0M | ||
| Q2 25 | $1.9B | $155.4M | ||
| Q1 25 | $980.0M | $110.4M | ||
| Q4 24 | $4.4B | $565.0M | ||
| Q3 24 | $3.3B | $527.4M | ||
| Q2 24 | $2.2B | $229.9M | ||
| Q1 24 | $459.0M | $154.8M |
自由现金流率AMGNPWR
| Q4 25 | 9.7% | 11.9% | ||
| Q3 25 | 44.4% | 5.5% | ||
| Q2 25 | 20.8% | 2.3% | ||
| Q1 25 | 12.0% | 1.8% | ||
| Q4 24 | 48.4% | 8.6% | ||
| Q3 24 | 39.0% | 8.1% | ||
| Q2 24 | 26.5% | 4.1% | ||
| Q1 24 | 6.2% | 3.1% |
资本支出强度AMGNPWR
| Q4 25 | 6.5% | 2.5% | ||
| Q3 25 | 4.6% | 1.9% | ||
| Q2 25 | 4.0% | 2.1% | ||
| Q1 25 | 5.0% | 2.1% | ||
| Q4 24 | 4.1% | 2.2% | ||
| Q3 24 | 3.0% | 3.3% | ||
| Q2 24 | 2.8% | 2.9% | ||
| Q1 24 | 3.1% | 1.7% |
现金转化率AMGNPWR
| Q4 25 | 1.20× | 3.56× | ||
| Q3 25 | 1.46× | 1.66× | ||
| Q2 25 | 1.59× | 1.29× | ||
| Q1 25 | 0.80× | 1.69× | ||
| Q4 24 | 7.61× | 2.29× | ||
| Q3 24 | 1.26× | 2.52× | ||
| Q2 24 | 3.30× | 2.08× | ||
| Q1 24 | — | 2.01× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMGN
| Products | $9.4B | 95% |
| Xgeva | $291.0M | 3% |
| Vectibix | $163.0M | 2% |
| Aranesp | $115.0M | 1% |
PWR
暂无分部数据
